Literature DB >> 10688103

Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism.

P E Radau1, R Linke, P J Slomka, K Tatsch.   

Abstract

UNLABELLED: Evaluation of therapies for parkinsonism by dopamine receptor SPECT requires a reproducible, optimized quantitation technique. This study presents a new, objective, automated technique for semiquantitative analysis of dopamine receptor density, as applied to the differential diagnosis of parkinsonism.
METHODS: Dopamine receptor density measured by 123I-iodobenzamide (IBZM) SPECT was retrospectively analyzed in nonidiopathic parkinsonism (NIPS), in Parkinson's disease (PD), and in healthy volunteers (n = 19, 38, and 13, respectively). A mean template was created from coregistered control studies. Registration errors were assessed using studies with simulated binding deficits. Patient studies were registered to the mean template, and striatal binding was calculated from a corresponding map of 3-dimensional regions of interest (ROIs). The striatal binding ratio and deficits determined by voxelwise comparison with the normal template were investigated and tested with various 3-dimensional ROI sizes and positions. Separation of patient groups was determined by tscore after automatically processing all studies. Results were compared with manual ROI analyses.
RESULTS: The automatic method was completely reproducible in 64 of 70 cases. The best diagnostic discriminator was the minimum binding ratio of the 2 striatal nuclei, with the following values: NIPS, 1.33+/-0.13; PD, 1.50+/-0.12; healthy volunteers, 1.49+/-0.08 (+/-SD). The deficit size from voxelwise analysis was: NIPS, 20.5+/-8.2 mL; PD, 9.5+/-8.3; healthy volunteers, 8.9+/-6.0 (+/-SD). The accuracy, measured by receiver operating characteristic areas, was 0.85+/-0.05, 0.77+/-0.06, and 0.80+/-0.06 (+/-SE) for the optimal predictor (automated) and 2 blinded observers (manual), respectively.
CONCLUSION: A new 3-dimensional, automated technique has been developed to semiquantitate receptor density that dramatically improves reproducibility. The optimal diagnostic discriminator of parkinsonism determined by the automatic technique has good accuracy compared with the manual technique.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688103

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

Review 1.  SPECT imaging evaluation in movement disorders: far beyond visual assessment.

Authors:  Kosmas Badiavas; Elisavet Molyvda; Ioannis Iakovou; Magdalini Tsolaki; Kyriakos Psarrakos; Nikolaos Karatzas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-02       Impact factor: 9.236

2.  Iterative reconstruction or filtered backprojection for semi-quantitative assessment of dopamine D₂ receptor SPECT studies?

Authors:  Walter Koch; Christine Suessmair; Klaus Tatsch; Gabriele Pöpperl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-02       Impact factor: 9.236

3.  Cross-camera comparison of SPECT measurements of a 3-D anthropomorphic basal ganglia phantom.

Authors:  Walter Koch; Perry E Radau; Wolfgang Münzing; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-25       Impact factor: 9.236

Review 4.  Multimodality image registration with software: state-of-the-art.

Authors:  Piotr J Slomka; Richard P Baum
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

5.  EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2.

Authors:  Koen Van Laere; Andrea Varrone; Jan Booij; Thierry Vander Borght; Flavio Nobili; Ozlem L Kapucu; Zuzana Walker; Kjell Någren; Klaus Tatsch; Jacques Darcourt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02       Impact factor: 9.236

6.  Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database.

Authors:  Flavio Nobili; Mehrdad Naseri; Fabrizio De Carli; Susan Asenbaum; Jan Booij; Jacques Darcourt; Peter Ell; Ozlem Kapucu; Paul Kemp; Claus Svarer; Claus Varer; Silvia Morbelli; Marco Pagani; Osama Sabri; Klaus Tatsch; Livia Tossici-Bolt; Terez Sera; Tierry Vander Borght; Koen Van Laere; Andrea Varrone
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-12       Impact factor: 9.236

7.  Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.

Authors:  Edward Ofori; Ofer Pasternak; Peggy J Planetta; Roxana Burciu; Amy Snyder; Marcelo Febo; Todd E Golde; Michael S Okun; David E Vaillancourt
Journal:  Neurobiol Aging       Date:  2014-10-31       Impact factor: 4.673

8.  Iterative reconstruction with correction of the spatially variant fan-beam collimator response in neurotransmission SPET imaging.

Authors:  Deborah Pareto; Albert Cot; Javier Pavía; Carles Falcón; Ignacio Juvells; Francisco Lomeña; Domènec Ros
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-03       Impact factor: 9.236

9.  Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer's disease.

Authors:  Tobias Tuszynski; Michael Rullmann; Julia Luthardt; Daniel Butzke; Solveig Tiepolt; Hermann-Josef Gertz; Swen Hesse; Anita Seese; Donald Lobsien; Osama Sabri; Henryk Barthel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-07       Impact factor: 9.236

10.  Methylphenidate effects on brain activity as a function of SLC6A3 genotype and striatal dopamine transporter availability.

Authors:  Anna-Maria Kasparbauer; Dan Rujescu; Michael Riedel; Oliver Pogarell; Anna Costa; Thomas Meindl; Christian la Fougère; Ulrich Ettinger
Journal:  Neuropsychopharmacology       Date:  2014-09-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.